2-(1H-吡咯-1-基)苯硫醇 | 43153-76-0

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 吡咯
• 中文名称: 2-(1H-吡咯-1-基)苯硫醇
• 英文名称: 1-(2-mercaptophenyl)-pyrrole
• 英文别名: 1-(2-mercaptophenyl)pyrrole；N-(2-mercaptophenyl)pyrrole；1-(2-mercaptofenil)pirrolo；2-pyrrol-1-yl-benzenethiol；1-(2-Mercaptophenyl)-pyrrol；2-pyrrol-1-ylbenzenethiol
• CAS: 43153-76-0
• 化学式: C₁₀H₉NS
• 分子量: 175.254
• InChiKey: LSRBGLOORJIITB-UHFFFAOYSA-N

物化性质

• 沸点：
  110-115 °C(Press: 0.05 Torr)
• 密度：
  1.12±0.1 g/cm3(Predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  2.5
• 重原子数：
  12
• 可旋转键数：
  1
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.0
• 拓扑面积：
  5.9
• 氢给体数：
  1
• 氢受体数：
  1

反应信息

• 作为反应物：
  描述：

  2-(1H-吡咯-1-基)苯硫醇 在 sodium hydroxide 、 lithium aluminium tetrahydride 、 三氯化铝 、 乙醇 、 五氯化磷 、 sodium acetate 、 sodium 作用下， 以 四氢呋喃 、 乙醇 为溶剂， 反应 51.25h， 生成 cis-7-acetoxy-6,7-dihydro-6-p-methoxyphenylpyrrolo<2,1-d><1,5>-benzothiazepine
  参考文献：
  名称：

  Nacci; Fiorini; Garofalo, Il Farmaco, 1990, vol. 45, # 5, p. 545 - 557

  摘要：

  DOI：
• 作为产物：
  描述：

  双(2-N-吡咯基苯基)二硫化物 在 红铝 作用下， 以 甲苯 为溶剂， 反应 1.75h， 以67%的产率得到2-(1H-吡咯-1-基)苯硫醇
  参考文献：
  名称：

  Bates, Dallas K.; Winters, R. Thomas; Burnell, A. Sell, Journal of Heterocyclic Chemistry, 1986, vol. 23, # 3, p. 695 - 699

  摘要：

  DOI：

文献信息

• Reactions of 2-(pyrrol-1-yl)benzyl radicals and related species under flash vacuum pyrolysis conditions
  作者：J. I. G. Cadogan、Bernard A. J. Clark、Daniel Ford、Ranald J. MacDonald、Andrew D. MacPherson、Hamish McNab、Iain S. Nicolson、David Reed、Craig C. Sommerville

  DOI：10.1039/b914965a

  日期：——

  2-(Pyrrol-1-yl)phenoxyl, aminyl, thiophenoxyl and benzyl radicals 2a–2d, respectively, were generated in the gas-phase under flash vacuum pyrolysis conditions. In all cases except the phenoxyl, cyclisation took place providing acceptable synthetic routes to the fused heterocycles 11, 14 and 15, respectively. Only sigmatropic rearrangement products were isolated, in low yields, from the phenoxyl 2a

  在闪蒸真空热解条件下，气相中分别生成了2-（吡咯-1-基）苯氧基，氨基，噻吩氧基和苄基2a-2d。在除苯氧所有情况下，环化发生提供可接受的合成路线的稠合杂环11，14和15分别。从苯氧基2a中仅以低收率分离出σ重排产物。这吡咯并[1,2- a ]苯并咪唑 11独家采用1 H-互变异构体氯仿解决方案。研究了吡咯并[2,1- b ]苯并噻吩14的亲电取代反应，包括质子化，氘交换，Vilsmeier甲酰化以及与乙炔二羧酸二甲酯。在相似的条件下，气相中还会生成2-（2,5-二芳基吡咯-1-基）硫代苯氧基，苯氧基和氨基自由基23a-f。所述thiophenoxyls 23A / b，得到由一次环化产物通过在pyrrrole环自由基的攻击和攻击在所形成的极其复杂的热分解物的混合物本位- ，邻-和间位-芳基环的位置。通过N-芳基的特定σ位移获得了次级热解产物。2，5-二（噻吩-2-基）噻吩氧基基团23c
• Generation and contrasting gas-phase reactivity of 2-(2-alkenylpyrrol-1-yl)phenoxyl and thiophenoxyl radicals
  作者：J. I. G. Cadogan、Chandralal M. Hewage、Hamish McNab、Andrew D. MacPherson、Iain S. Nicolson、David Reed、Ian H. Sadler

  DOI：10.1039/b604727k

  日期：——

  The pyrrolylacrylates 9 and 10 were synthesised and subjected to flash vacuum pyrolysis (FVP) at 650–700 °C to generate the radicals 11 and 18, respectively. The phenoxyl 11 underwent hydrogen capture to give a mixture of the phenol 12 and the pyrrolobenzoxazine 13 in low yields, which were also obtained by a Wittig reaction of the 2-formylpyrrole 14. The thiophenoxyl 18 gave a single major product in 41% yield which was identified as the pyrrolo[1,2-a]quinoline 17 by a sequence of NMR experiments. A mechanism for the formation of 17 by a rearrangement–sulfur extrusion sequence is proposed.

  合成吡咯烷丙烯酸酯 9 和 10 后，在 650-700 °C 下进行闪速真空热解 (FVP)，分别生成自由基 11 和 18。苯氧基 11 经过氢捕获，得到苯酚 12 和吡咯并恶嗪 13 的混合物，产量较低，这两种物质也是通过 2-甲酰基吡咯 14 的维蒂希反应得到的。通过一系列核磁共振实验，噻吩氧 18 得到了单一的主要产物，收率为 41%，该产物被确认为吡咯并[1,2-a]喹啉 17。提出了通过重排-硫挤出序列形成 17 的机理。
• Apoptosis-inducing compounds
  申请人：The Universita'di Siena

  公开号：US06806267B1

  公开（公告）日：2004-10-19

  The present invention relates to pyrrolobenzoxazepines, pyrrolobenzthiazepines and related compounds having the ability to induce apoptosis, to pharmaceutical compositions comprising these compounds and to their use as anti-tumour agents.

  本发明涉及能够诱导细胞凋亡的吡咯苯并噁唑环烯和吡咯苯并噻唑环烯以及相关化合物，涉及包含这些化合物的药物组合物，以及它们作为抗肿瘤剂的用途。
• [EN] APOPTOSIS-INDUCING COMPOUNDS<br/>[FR] COMPOSES INDUISANT L'APOPTOSE
  申请人：TRINITY COLLEGE DUBLIN

  公开号：WO2001058904A1

  公开（公告）日：2001-08-16

  The invention relates to a pharmaceutical composition comprising an apoptosis-inducing amount of a compound having general formula (I), wherein: (i) R1 represents an unsubstituted C6 or C10 aryl group; or a C6 aryl group substituted with Me or OMe; (ii) A represents O, S or S partially oxidized to sulfoxide; (iii) the cyclic group labelled F represents an unsubstituted C6 or C10 aryl-fused group or a C5 heteroaryl-fused group (nitrogen as heteroatom) or a benzo-fused system substituted with ethoxycarbonyl function; (iv) and Y represents the group (A) wherein R2 and R3 are independently hydrogen; or methyl; or Y represents the group CH3 or a (CH2)2CH3 group; or an unsubstituted C5 heteroaryl group (nitrogen as heteroatom). The compositions may be used for the treatment of tumours or other cancerous conditions, such as CML (chronic myeloid leukaemia), AML, in AIDS-related lymphomas (such as Karpowski's sarcoma, a sub-cutaneous lymphoma) and used as apoptotic agents in the treatment of cancers generally.

  本发明涉及一种药物组合物，包含一定量的通式（I）化合物，其诱导细胞凋亡的作用，其中：（i）R1代表未取代的C6或C10芳基；或取代有Me或OMe的C6芳基；（ii）A代表O，S或部分氧化为亚砜的S；（iii）标记为F的环状基团代表未取代的C6或C10芳基融合基团或取代有乙氧羰基的苯融合系统或C5杂环芳基融合基团（杂原子为氮）；（iv）Y代表基团（A），其中R2和R3独立地代表氢；或甲基；或Y代表基团CH3或（CH2）2 基团；或未取代的C5杂环芳基（杂原子为氮）。该组合物可用于治疗肿瘤或其他癌症疾病，如慢性髓性白血病（CML）、急性髓性白血病（AML）、艾滋病相关淋巴瘤（如卡波夫斯基肉瘤，一种皮下淋巴瘤）并可作为凋亡剂用于治疗各种癌症。
• Pyrrolo[1,5]benzoxa(thia)zepines as a New Class of Potent Apoptotic Agents. Biological Studies and Identification of an Intracellular Location of Their Drug Target
  作者：Margaret M. Mc Gee、Sandra Gemma、Stefania Butini、Anna Ramunno、Daniela M. Zisterer、Caterina Fattorusso、Bruno Catalanotti、Gagan Kukreja、Isabella Fiorini、Claudio Pisano、Carla Cucco、Ettore Novellino、Vito Nacci、D. Clive Williams、Giuseppe Campiani

  DOI：10.1021/jm049402y

  日期：2005.6.1

  We have recently developed five novel pyrrolo-1,5-benzoxazepines as proapoptotic agents. Their JNK-dependent induction of apoptosis in tumor cells suggested their potential as novel anticancer agents. The core structure of the apoptotic agent 6 was investigated, and the SARs were expanded with the design and synthesis of several analogues. To define the apoptotic mechanism of the new compounds and the localization of their drug target, two analogues of 6 were designed and synthesized to delineate events leading to JNK activation. The cell-penetrating compound 16 induced apoptosis in tumor cells, while its nonpenetrating analogue, 17, was incapable of inducing apoptosis or activating JNK. Plasma membrane permeabilization of tumor cells resulted in 17-induced JNK activation, suggesting that the pyrrolo-1,5-benzoxazepine molecular target is intracellular. Interestingly, compound 6 displayed cytotoxic activity against a panel of human tumor cell lines but demonstrated negligible toxicity in vivo with no effect on the animals' hematology parameters.